Michele Bernardini
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Michele Bernardini has a total of 45 co-authors. Here are the top co-authors by number of shared publications:
- Emanuele Frontoni
Department of Political Sciences, Communication and International Relations, University of Macerata, Macerata, Italy
10 shared publications - Luca Romeo
Department Economics and Law, University of Macerata, Macerata, Italy
10 shared publications Emanuele Frontoni
Department of Theoretical and Applied Sciences (DiSTA), eCampus University, Como, Italy
3 shared publicationsAnnalisa Cenci
Università Politecnica delle Marche, Ancona, Italy
2 shared publicationsChiara Calamanti
Dipartimento di Ingegneria dell'Informazione (DII), Universita Politecnica delle Marche, Ancona, Italy
2 shared publications- Laura Burattini
Department of Information Engineering, Università Politecnica delle Marche, Via Brecce Bianche 12, 60131 Ancona, Italy
2 shared publications
Latest Publications
- Open Access
- 31 March 2026
- Published by Elsevier in Applied Soft Computing
- Vol. 197
Ordinal evolutionary artificial neural networks for predicting diabetic nephropathy progression
- 31 March 2026
- Published by Elsevier in Applied Soft Computing
- Vol. 197
Open AccessOrdinal evolutionary artificial neural networks for predicting diabetic nephropathy progression
- Open Access
- 17 March 2026
- Published by Association for Computing Machinery (ACM) in ACM Transactions on Computing for Healthcare
- Vol. 7 (2) , 1-28
Machine Learning-Based Clinical Decision Support System for Hepatic Fibrosis Risk Prediction in General Practice
Hepatic steatosis, or non-alcoholic fatty liver disease (NAFLD), affects a significant portion of the global population and can lead to more severe liver conditions, including hepatic fibrosis. Early and accurate risk prediction of fibrosis is crucial for timely intervention. Traditional diagnostic methods are invasive and carry risks, while imaging techniques and blood-based biomarkers have limitations in routine general practice. This study presents a machine learning-based clinical decision support system designed to assess the risk of hepatic fibrosis in patients with NAFLD using routine laboratory tests. The framework is developed using electronic health record data collected over 15 years, initially encompassing 1,272,572 patients from general practice. After applying clinical selection criteria, two cohorts of 12,960 and 25,478 patients were used for model development and evaluation. The proposed approach provides a robust foundation for monitoring fibrosis risk by implementing a novel screening method, which preprocesses predictors by leveraging well-established clinical indicators (e.g., hepatic steatosis index, fibrosis-4 index), alongside a selected minimal number of predictors, making it practical and cost-effective for widespread clinical use. The study’s findings indicate promising results for screening and monitoring fibrosis risk in NAFLD patients, achieving the best AUC of 92.97%, PRAUC of 75.44%, and Sensitivity of 79.63%.
- 17 March 2026
- Published by Association for Computing Machinery (ACM) in ACM Transactions on Computing for Healthcare
- Vol. 7 (2) , 1-28
Open AccessMachine Learning-Based Clinical Decision Support System for Hepatic Fibrosis Risk Prediction in General Practice
Hepatic steatosis, or non-alcoholic fatty liver disease (NAFLD), affects a significant portion of the global population and can lead to more severe liver conditions, including hepatic fibrosis. Early and accurate risk prediction of fibrosis is crucial for timely intervention. Traditional diagnostic methods are invasive and carry risks, while imaging techniques and blood-based biomarkers have limitations in routine general practice. This study presents a machine learning-based clinical decision support system designed to assess the risk of hepatic fibrosis in patients with NAFLD using routine laboratory tests. The framework is developed using electronic health record data collected over 15 years, initially encompassing 1,272,572 patients from general practice. After applying clinical selection criteria, two cohorts of 12,960 and 25,478 patients were used for model development and evaluation. The proposed approach provides a robust foundation for monitoring fibrosis risk by implementing a novel screening method, which preprocesses predictors by leveraging well-established clinical indicators (e.g., hepatic steatosis index, fibrosis-4 index), alongside a selected minimal number of predictors, making it practical and cost-effective for widespread clinical use. The study’s findings indicate promising results for screening and monitoring fibrosis risk in NAFLD patients, achieving the best AUC of 92.97%, PRAUC of 75.44%, and Sensitivity of 79.63%.
- 14 September 2025
- Published by Elsevier in Diabetes Research and Clinical Practice
- Vol. 229, 112900
A machine learning algorithm for the prediction of complications incorporated in electronic medical records improves type 2 diabetes care
- 14 September 2025
- Published by Elsevier in Diabetes Research and Clinical Practice
- Vol. 229, 112900
A machine learning algorithm for the prediction of complications incorporated in electronic medical records improves type 2 diabetes care
- Open Access
- 22 June 2023
- Published by Elsevier in Computers in Biology and Medicine
- Vol. 163, 107188
A novel missing data imputation approach based on clinical conditional Generative Adversarial Networks applied to EHR datasets
- 22 June 2023
- Published by Elsevier in Computers in Biology and Medicine
- Vol. 163, 107188
Open AccessA novel missing data imputation approach based on clinical conditional Generative Adversarial Networks applied to EHR datasets
- Open Access
- 10 November 2021
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Access
- Vol. 9, 151864-151872
A Clinical Decision Support System to Stratify the Temporal Risk of Diabetic Retinopathy
Diabetic Retinopathy (DR) is the most common and insidious microvascular complication of diabetes, and can progress asymptomatically until a sudden loss of vision occurs. Although DR is prevalent nowadays, its prevention remains challenging. The multiple aim of this study was to predict the risk of developing DR as diabetic complication (task 1) and, subsequently, temporally stratify the DR risk (task 2) using electronic health records data. To perform these objectives, a novel preprocessing procedure was designed to select both control and pathological patients, and moreover, a novel fully annotated/standardized 120K dataset from multiple diabetologic centers was provided. Globally, although the Extreme Gradient Boosting model offers satisfying predictive performance, the Random Forest model obtained the best predictive performance to solve task 1 and task 2, reaching the best Area Under the Precision-Recall Curve of 72.43 % and 84.38 %, respectively. Also the features importance extracted from the best Machine Learning (ML) models is provided. The proposed Artificial Intelligence-based solution was proven to be capable of generalizing across different diabetologic centers while ensuring high-interpretability. Moreover, the proposed ML solution is currently being adopted as a Clinical Decision Support System in several diabetologic centers for DR screening and follow-up purposes.
- 10 November 2021
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Access
- Vol. 9, 151864-151872
Open AccessA Clinical Decision Support System to Stratify the Temporal Risk of Diabetic Retinopathy
Diabetic Retinopathy (DR) is the most common and insidious microvascular complication of diabetes, and can progress asymptomatically until a sudden loss of vision occurs. Although DR is prevalent nowadays, its prevention remains challenging. The multiple aim of this study was to predict the risk of developing DR as diabetic complication (task 1) and, subsequently, temporally stratify the DR risk (task 2) using electronic health records data. To perform these objectives, a novel preprocessing procedure was designed to select both control and pathological patients, and moreover, a novel fully annotated/standardized 120K dataset from multiple diabetologic centers was provided. Globally, although the Extreme Gradient Boosting model offers satisfying predictive performance, the Random Forest model obtained the best predictive performance to solve task 1 and task 2, reaching the best Area Under the Precision-Recall Curve of 72.43 % and 84.38 %, respectively. Also the features importance extracted from the best Machine Learning (ML) models is provided. The proposed Artificial Intelligence-based solution was proven to be capable of generalizing across different diabetologic centers while ensuring high-interpretability. Moreover, the proposed ML solution is currently being adopted as a Clinical Decision Support System in several diabetologic centers for DR screening and follow-up purposes.
- 20 April 2021
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Journal of Biomedical and Health Informatics
- Vol. 25 (10) , 3983-3994
A Semi-Supervised Multi-Task Learning Approach for Predicting Short-Term Kidney Disease Evolution
Kidney Disease (KD) may hide complex causes and is associated with a tremendous socio-economic impact. A timely identification and management from the first level of medical care represent the most effective strategy to address the growing global burden sustainably. Clinical practice guidelines suggest utilizing estimated Glomerular Filtration Rate (eGFR) for routine evaluation within a screening purpose. Accordingly, the analysis of Electronic Health Records (EHRs) using Machine Learning techniques offers great opportunities to monitor and predict the eGFR trend over time. This paper aims to propose a novel Semi-Supervised Multi-Task Learning (SS-MTL) approach for predicting short-term KD evolution on multiple General Practitioners EHR data. We demonstrated that the SS-MTL approach is able to (i) capture the eGFR temporal evolution by imposing a temporal relatedness between consecutive time-windows and (ii) exploit useful information from unlabeled patients when labeled patients are less numerous with a gain of up to 4.1 % in terms of Recall. This situation reflects the real-case scenario, where available labeled samples are limited, but those unlabeled much more abundant. The SS-MTL approach, also given the high level of interpretability, might be the ideal candidate in general practice to get integrated within a decision support system for KD screening purposes.
- 20 April 2021
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Journal of Biomedical and Health Informatics
- Vol. 25 (10) , 3983-3994
A Semi-Supervised Multi-Task Learning Approach for Predicting Short-Term Kidney Disease Evolution
Kidney Disease (KD) may hide complex causes and is associated with a tremendous socio-economic impact. A timely identification and management from the first level of medical care represent the most effective strategy to address the growing global burden sustainably. Clinical practice guidelines suggest utilizing estimated Glomerular Filtration Rate (eGFR) for routine evaluation within a screening purpose. Accordingly, the analysis of Electronic Health Records (EHRs) using Machine Learning techniques offers great opportunities to monitor and predict the eGFR trend over time. This paper aims to propose a novel Semi-Supervised Multi-Task Learning (SS-MTL) approach for predicting short-term KD evolution on multiple General Practitioners EHR data. We demonstrated that the SS-MTL approach is able to (i) capture the eGFR temporal evolution by imposing a temporal relatedness between consecutive time-windows and (ii) exploit useful information from unlabeled patients when labeled patients are less numerous with a gain of up to 4.1 % in terms of Recall. This situation reflects the real-case scenario, where available labeled samples are limited, but those unlabeled much more abundant. The SS-MTL approach, also given the high level of interpretability, might be the ideal candidate in general practice to get integrated within a decision support system for KD screening purposes.
- Open Access
- 1 January 2020
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Journal of Translational Engineering in Health and Medicine
- Vol. 8, 1-12
A Decision Support System for Diabetes Chronic Care Models Based on General Practitioner Engagement and EHR Data Sharing
Objective Decision support systems (DSS) have been developed and promoted for their potential to improve quality of health care. However, there is a lack of common clinical strategy and a poor management of clinical resources and erroneous implementation of preventive medicine. Methods To overcome this problem, this work proposed an integrated system that relies on the creation and sharing of a database extracted from GPs' Electronic Health Records (EHRs) within the Netmedica Italian (NMI) cloud infrastructure. Although the proposed system is a pilot application specically tailored for improving the chronic Type 2 Diabetes (T2D) care it could be easily targeted to effectively manage different chronicdiseases. The proposed DSS is based on EHR structure used by GPs in their daily activities following the most updated guidelines in data protection and sharing. The DSS is equipped with a Machine Learning (ML) method for analyzing the shared EHRs and thus tackling the high variability of EHRs. A novel set of T2D care-quality indicators are used specically to determine the economic incentives and the T2D features are presented as predictors of the proposed ML approach. Results The EHRs from 41237 T2D patients were analyzed. No additional data collection, with respect to the standard clinical practice, was required. The DSS exhibited competitive performance (up to an overall accuracy of 98% +/- 2% and macro-recall of 96%+/- 1%) for classifying chronic care quality across the different follow-up phases. The chronic care quality model brought to a signicant increase (up to 12%) of the T2D patients without complications. For GPs who agreed to use the proposed system, there was an economic incentive. A further bonus was assigned when performance targets are achieved. Conclusions The quality care evaluation in a clinical use-case scenario demonstrated how the empowerment of the GPs through the use of the platform (integrating the proposed DSS), along with the economic incentives, may speed up the improvement of care.
- 1 January 2020
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Journal of Translational Engineering in Health and Medicine
- Vol. 8, 1-12
Open AccessA Decision Support System for Diabetes Chronic Care Models Based on General Practitioner Engagement and EHR Data Sharing
Objective Decision support systems (DSS) have been developed and promoted for their potential to improve quality of health care. However, there is a lack of common clinical strategy and a poor management of clinical resources and erroneous implementation of preventive medicine. Methods To overcome this problem, this work proposed an integrated system that relies on the creation and sharing of a database extracted from GPs' Electronic Health Records (EHRs) within the Netmedica Italian (NMI) cloud infrastructure. Although the proposed system is a pilot application specically tailored for improving the chronic Type 2 Diabetes (T2D) care it could be easily targeted to effectively manage different chronicdiseases. The proposed DSS is based on EHR structure used by GPs in their daily activities following the most updated guidelines in data protection and sharing. The DSS is equipped with a Machine Learning (ML) method for analyzing the shared EHRs and thus tackling the high variability of EHRs. A novel set of T2D care-quality indicators are used specically to determine the economic incentives and the T2D features are presented as predictors of the proposed ML approach. Results The EHRs from 41237 T2D patients were analyzed. No additional data collection, with respect to the standard clinical practice, was required. The DSS exhibited competitive performance (up to an overall accuracy of 98% +/- 2% and macro-recall of 96%+/- 1%) for classifying chronic care quality across the different follow-up phases. The chronic care quality model brought to a signicant increase (up to 12%) of the T2D patients without complications. For GPs who agreed to use the proposed system, there was an economic incentive. A further bonus was assigned when performance targets are achieved. Conclusions The quality care evaluation in a clinical use-case scenario demonstrated how the empowerment of the GPs through the use of the platform (integrating the proposed DSS), along with the economic incentives, may speed up the improvement of care.
- 1 September 2019
- Published by Elsevier in Computers in Biology and Medicine
- Vol. 112, 103358
TyG-er: An ensemble Regression Forest approach for identification of clinical factors related to insulin resistance condition using Electronic Health Records
- 1 September 2019
- Published by Elsevier in Computers in Biology and Medicine
- Vol. 112, 103358
TyG-er: An ensemble Regression Forest approach for identification of clinical factors related to insulin resistance condition using Electronic Health Records
- 13 February 2019
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Journal of Biomedical and Health Informatics
- Vol. 24 (1) , 235-246
Discovering the Type 2 Diabetes in Electronic Health Records Using the Sparse Balanced Support Vector Machine
The diagnosis of type 2 diabetes (T2D) at an early stage has a key role for an adequate T2D integrated management system and patient's follow-up. Recent years have witnessed an increasing amount of available electronic health record (EHR) data and machine learning (ML) techniques have been considerably evolving. However, managing and modeling this amount of information may lead to several challenges, such as overfitting, model interpretability, and computational cost. Starting from these motivations, we introduced an ML method called sparse balanced support vector machine (SB-SVM) for discovering T2D in a novel collected EHR dataset (named Federazione Italiana Medici di Medicina Generale dataset). In particular, among all the EHR features related to exemptions, examination, and drug prescriptions, we have selected only those collected before T2D diagnosis from an uniform age group of subjects. We demonstrated the reliability of the introduced approach with respect to other ML and deep learning approaches widely employed in the state-of-the-art for solving this task. Results evidence that the SB-SVM overcomes the other state-of-the-art competitors providing the best compromise between predictive performance and computation time. Additionally, the induced sparsity allows to increase the model interpretability, while implicitly managing high-dimensional data and the usual unbalanced class distribution.
- 13 February 2019
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Journal of Biomedical and Health Informatics
- Vol. 24 (1) , 235-246
Discovering the Type 2 Diabetes in Electronic Health Records Using the Sparse Balanced Support Vector Machine
The diagnosis of type 2 diabetes (T2D) at an early stage has a key role for an adequate T2D integrated management system and patient's follow-up. Recent years have witnessed an increasing amount of available electronic health record (EHR) data and machine learning (ML) techniques have been considerably evolving. However, managing and modeling this amount of information may lead to several challenges, such as overfitting, model interpretability, and computational cost. Starting from these motivations, we introduced an ML method called sparse balanced support vector machine (SB-SVM) for discovering T2D in a novel collected EHR dataset (named Federazione Italiana Medici di Medicina Generale dataset). In particular, among all the EHR features related to exemptions, examination, and drug prescriptions, we have selected only those collected before T2D diagnosis from an uniform age group of subjects. We demonstrated the reliability of the introduced approach with respect to other ML and deep learning approaches widely employed in the state-of-the-art for solving this task. Results evidence that the SB-SVM overcomes the other state-of-the-art competitors providing the best compromise between predictive performance and computation time. Additionally, the induced sparsity allows to increase the model interpretability, while implicitly managing high-dimensional data and the usual unbalanced class distribution.